New insider activity at Prestige Consumer Healthcare ( (PBH) ) has taken place on March 6, 2025.
Mary Beth Fritz, the Senior Vice President of Quality & Regulatory at Prestige Consumer Healthcare, recently executed a significant transaction by selling 6,297 shares of the company’s stock. This sale amounted to a total value of $537,700.
Recent Updates on PBH stock
Prestige Consumer Healthcare has seen a positive shift in its stock price targets following its strong Q3 earnings report. Oppenheimer, DA Davidson, and Canaccord have all raised their price targets for the company, citing various factors. Oppenheimer remains confident in the company’s long-term prospects after meetings with senior management, while DA Davidson highlights the company’s Q3 sales and earnings beats, particularly noting the increase in Summer’s Eve sales and Clear Eyes shipments. DA Davidson also adjusted its valuation model, increasing the free cash flow growth rate. Canaccord points to the company’s robust Q3 results, strong cash generation, and a diverse brand portfolio as reasons for their price target increase. The company’s record quarterly sales and earnings per share, driven by international growth and strategic debt reduction, have contributed to a positive outlook despite challenges such as supply chain constraints and economic uncertainties.
More about Prestige Consumer Healthcare
YTD Price Performance: 8.38%
Average Trading Volume: 300,348
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $4.17B